Skip to content

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

  1. Home/
  2. Our company/
  3. In Front of Cancer: Mary’s Story
Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson sitting at a table being interviewed

In Front of Cancer: Mary’s Story

Each day, we are working toward our ambition to get in front of cancer.

For Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson, this work is deeply personal. Her story, and the stories of patients everywhere, inspire and remind us why we will never settle until the disease is behind everyone.

More from Johnson & Johnson

Juvenile myasthenia gravis: Inside one adolescent’s journey

The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.

5 ways Johnson & Johnson is innovating in medicines and therapies

From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community

Teaming up to support healthcare in the local community and empower residents.